BioXcel Therapeutics, Inc. (BTAI)
1.06
-0.02
(-1.85%)
USD |
NASDAQ |
Apr 10, 16:00
1.07
+0.01
(+0.94%)
After-Hours: 20:00
BioXcel Therapeutics Market Cap : 28.70M for April 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rigel Pharmaceuticals, Inc. | 539.41M |
| Puma Biotechnology, Inc. | 395.82M |
| Quince Therapeutics, Inc. | 7.589M |
| ACADIA Pharmaceuticals, Inc. | 3.707B |
| Alnylam Pharmaceuticals, Inc. | 42.72B |
Market Cap Related Metrics
| PS Ratio | 16.13 |
| PEG Ratio | -0.0034 |
| Price | 1.06 |
| Earnings Yield | -674.7% |
| PEGY Ratio | -0.0034 |